nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—Gemcitabine—pancreatic cancer	0.286	1	CrCtD
Decitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.21	0.515	CiPCiCtD
Decitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.198	0.485	CiPCiCtD
Decitabine—DCK—Gemcitabine—pancreatic cancer	0.082	1	CbGbCtD
Decitabine—Lamivudine—Gemcitabine—pancreatic cancer	0.0623	0.374	CrCrCtD
Decitabine—Zalcitabine—Gemcitabine—pancreatic cancer	0.0539	0.323	CrCrCtD
Decitabine—Cytarabine—Gemcitabine—pancreatic cancer	0.0259	0.155	CrCrCtD
Decitabine—Azacitidine—Gemcitabine—pancreatic cancer	0.0246	0.147	CrCrCtD
Decitabine—DCK—Pyrimidine salvage reactions—TYMP—pancreatic cancer	0.00154	0.135	CbGpPWpGaD
Decitabine—DCK—Pyrimidine metabolism—TYMP—pancreatic cancer	0.0007	0.0616	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CFLAR—pancreatic cancer	0.000616	0.0542	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—NDRG1—pancreatic cancer	0.000616	0.0542	CbGpPWpGaD
Decitabine—DCK—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000555	0.0489	CbGpPWpGaD
Decitabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000514	0.568	CbGdCrCtD
Decitabine—DNMT3A—One Carbon Metabolism—TYMS—pancreatic cancer	0.0005	0.044	CbGpPWpGaD
Decitabine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.00045	0.0396	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—GADD45A—pancreatic cancer	0.000355	0.0312	CbGpPWpGaD
Decitabine—Floxuridine—TYMP—pancreatic cancer	0.000347	0.203	CrCbGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—CHD3—pancreatic cancer	0.000339	0.0298	CbGpPWpGaD
Decitabine—DNMT1—One Carbon Metabolism—TYMS—pancreatic cancer	0.000338	0.0297	CbGpPWpGaD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—EZH2—pancreatic cancer	0.000332	0.0292	CbGpPWpGaD
Decitabine—DCK—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000317	0.0278	CbGpPWpGaD
Decitabine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.000304	0.0267	CbGpPWpGaD
Decitabine—Trifluridine—TYMP—pancreatic cancer	0.000276	0.162	CrCbGaD
Decitabine—DCK—Nucleotide metabolism—TYMP—pancreatic cancer	0.000273	0.024	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—SMAD4—pancreatic cancer	0.000266	0.0234	CbGpPWpGaD
Decitabine—Zalcitabine—SLC29A1—pancreatic cancer	0.000263	0.154	CrCbGaD
Decitabine—Gemcitabine—SLC29A1—pancreatic cancer	0.000259	0.152	CrCbGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—EZH2—pancreatic cancer	0.000224	0.0197	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—TSC2—pancreatic cancer	0.000217	0.0191	CbGpPWpGaD
Decitabine—DCK—Nucleotide metabolism—DPYD—pancreatic cancer	0.000216	0.019	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—EZH2—pancreatic cancer	0.000213	0.0187	CbGpPWpGaD
Decitabine—Cytarabine—SLC29A1—pancreatic cancer	0.000177	0.103	CrCbGaD
Decitabine—Floxuridine—TYMS—pancreatic cancer	0.000163	0.0956	CrCbGaD
Decitabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	0.000158	0.175	CbGdCrCtD
Decitabine—DNMT1—Epigenetic regulation of gene expression—EZH2—pancreatic cancer	0.000144	0.0127	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000136	0.012	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MET—pancreatic cancer	0.000133	0.0117	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—pancreatic cancer	0.000132	0.0116	CbGpPWpGaD
Decitabine—Trifluridine—TYMS—pancreatic cancer	0.00013	0.076	CrCbGaD
Decitabine—DCK—Nucleotide metabolism—TYMS—pancreatic cancer	0.000123	0.0108	CbGpPWpGaD
Decitabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	0.000121	0.134	CbGdCrCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—PPARG—pancreatic cancer	0.000121	0.0106	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—RB1—pancreatic cancer	0.000115	0.0102	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—CCND1—pancreatic cancer	0.000115	0.0101	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000113	0.00994	CbGpPWpGaD
Decitabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	0.000112	0.124	CbGdCrCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—pancreatic cancer	0.000106	0.00929	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—pancreatic cancer	0.000101	0.00893	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	9.25e-05	0.00814	CbGpPWpGaD
Decitabine—Gemcitabine—TYMS—pancreatic cancer	9.22e-05	0.054	CrCbGaD
Decitabine—DNMT3A—Gene Expression—CHD3—pancreatic cancer	8.98e-05	0.0079	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND1—pancreatic cancer	8.57e-05	0.00754	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	7.66e-05	0.00674	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—NR5A2—pancreatic cancer	7.52e-05	0.00662	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	6.87e-05	0.00605	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—CHD3—pancreatic cancer	6.06e-05	0.00533	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	5.69e-05	0.005	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	5.51e-05	0.00485	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—NR5A2—pancreatic cancer	5.08e-05	0.00447	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—CCND1—pancreatic cancer	4.9e-05	0.00431	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	4.56e-05	0.00401	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	4.53e-05	0.00398	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—MEN1—pancreatic cancer	4.32e-05	0.0038	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—NOTCH4—pancreatic cancer	4.1e-05	0.0036	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—HSPA1B—pancreatic cancer	3.91e-05	0.00344	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	3.75e-05	0.0033	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—EZH2—pancreatic cancer	3.56e-05	0.00313	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—NOTCH3—pancreatic cancer	3.48e-05	0.00306	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—HSPA1A—pancreatic cancer	3.3e-05	0.0029	CbGpPWpGaD
Decitabine—DCK—Metabolism—PRSS1—pancreatic cancer	3.27e-05	0.00288	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MEN1—pancreatic cancer	2.92e-05	0.00257	CbGpPWpGaD
Decitabine—DCK—Metabolism—ARG2—pancreatic cancer	2.84e-05	0.00249	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—NOTCH4—pancreatic cancer	2.77e-05	0.00243	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—HSPA1B—pancreatic cancer	2.64e-05	0.00232	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—SMAD4—pancreatic cancer	2.62e-05	0.00231	CbGpPWpGaD
Decitabine—DCK—Metabolism—TYMP—pancreatic cancer	2.48e-05	0.00218	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—EZH2—pancreatic cancer	2.4e-05	0.00211	CbGpPWpGaD
Decitabine—Body temperature increased—Irinotecan—pancreatic cancer	2.4e-05	0.000544	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	2.4e-05	0.000544	CcSEcCtD
Decitabine—Feeling abnormal—Fluorouracil—pancreatic cancer	2.4e-05	0.000543	CcSEcCtD
Decitabine—Bronchitis—Epirubicin—pancreatic cancer	2.39e-05	0.000543	CcSEcCtD
Decitabine—Nasopharyngitis—Doxorubicin—pancreatic cancer	2.38e-05	0.00054	CcSEcCtD
Decitabine—Anaemia—Docetaxel—pancreatic cancer	2.38e-05	0.000539	CcSEcCtD
Decitabine—Pancytopenia—Epirubicin—pancreatic cancer	2.36e-05	0.000536	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NOTCH3—pancreatic cancer	2.35e-05	0.00207	CbGpPWpGaD
Decitabine—Muscular weakness—Doxorubicin—pancreatic cancer	2.35e-05	0.000533	CcSEcCtD
Decitabine—Vomiting—Sunitinib—pancreatic cancer	2.34e-05	0.000531	CcSEcCtD
Decitabine—Body temperature increased—Gemcitabine—pancreatic cancer	2.34e-05	0.00053	CcSEcCtD
Decitabine—Neutropenia—Epirubicin—pancreatic cancer	2.33e-05	0.000528	CcSEcCtD
Decitabine—Dysuria—Epirubicin—pancreatic cancer	2.33e-05	0.000528	CcSEcCtD
Decitabine—Rash—Sunitinib—pancreatic cancer	2.32e-05	0.000527	CcSEcCtD
Decitabine—Dermatitis—Sunitinib—pancreatic cancer	2.32e-05	0.000526	CcSEcCtD
Decitabine—Abdominal distension—Doxorubicin—pancreatic cancer	2.32e-05	0.000525	CcSEcCtD
Decitabine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	2.31e-05	0.000524	CcSEcCtD
Decitabine—Urticaria—Fluorouracil—pancreatic cancer	2.31e-05	0.000523	CcSEcCtD
Decitabine—Headache—Sunitinib—pancreatic cancer	2.31e-05	0.000523	CcSEcCtD
Decitabine—Dysphagia—Doxorubicin—pancreatic cancer	2.3e-05	0.000522	CcSEcCtD
Decitabine—Leukopenia—Docetaxel—pancreatic cancer	2.3e-05	0.000522	CcSEcCtD
Decitabine—Pollakiuria—Epirubicin—pancreatic cancer	2.3e-05	0.000521	CcSEcCtD
Decitabine—Body temperature increased—Fluorouracil—pancreatic cancer	2.3e-05	0.000521	CcSEcCtD
Decitabine—Weight decreased—Epirubicin—pancreatic cancer	2.25e-05	0.00051	CcSEcCtD
Decitabine—Hyperglycaemia—Epirubicin—pancreatic cancer	2.24e-05	0.000509	CcSEcCtD
Decitabine—Cough—Docetaxel—pancreatic cancer	2.24e-05	0.000509	CcSEcCtD
Decitabine—Hypersensitivity—Irinotecan—pancreatic cancer	2.24e-05	0.000507	CcSEcCtD
Decitabine—Pneumonia—Epirubicin—pancreatic cancer	2.23e-05	0.000506	CcSEcCtD
Decitabine—DNMT1—Gene Expression—HSPA1A—pancreatic cancer	2.23e-05	0.00196	CbGpPWpGaD
Decitabine—Hypertension—Docetaxel—pancreatic cancer	2.22e-05	0.000503	CcSEcCtD
Decitabine—Infestation NOS—Epirubicin—pancreatic cancer	2.22e-05	0.000503	CcSEcCtD
Decitabine—Infestation—Epirubicin—pancreatic cancer	2.22e-05	0.000503	CcSEcCtD
Decitabine—Bronchitis—Doxorubicin—pancreatic cancer	2.21e-05	0.000502	CcSEcCtD
Decitabine—Myalgia—Docetaxel—pancreatic cancer	2.19e-05	0.000496	CcSEcCtD
Decitabine—Arthralgia—Docetaxel—pancreatic cancer	2.19e-05	0.000496	CcSEcCtD
Decitabine—Chest pain—Docetaxel—pancreatic cancer	2.19e-05	0.000496	CcSEcCtD
Decitabine—Nausea—Sunitinib—pancreatic cancer	2.19e-05	0.000496	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—pancreatic cancer	2.19e-05	0.000496	CcSEcCtD
Decitabine—Renal failure—Epirubicin—pancreatic cancer	2.18e-05	0.000494	CcSEcCtD
Decitabine—Asthenia—Irinotecan—pancreatic cancer	2.18e-05	0.000494	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.17e-05	0.000493	CcSEcCtD
Decitabine—Stomatitis—Epirubicin—pancreatic cancer	2.16e-05	0.00049	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—pancreatic cancer	2.16e-05	0.000489	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—pancreatic cancer	2.15e-05	0.000488	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—pancreatic cancer	2.15e-05	0.000488	CcSEcCtD
Decitabine—Hypersensitivity—Fluorouracil—pancreatic cancer	2.14e-05	0.000485	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	2.14e-05	0.000485	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—pancreatic cancer	2.13e-05	0.000482	CcSEcCtD
Decitabine—Asthenia—Gemcitabine—pancreatic cancer	2.12e-05	0.000481	CcSEcCtD
Decitabine—Confusional state—Docetaxel—pancreatic cancer	2.12e-05	0.00048	CcSEcCtD
Decitabine—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.1e-05	0.000476	CcSEcCtD
Decitabine—Anaphylactic shock—Docetaxel—pancreatic cancer	2.1e-05	0.000476	CcSEcCtD
Decitabine—Oedema—Docetaxel—pancreatic cancer	2.1e-05	0.000476	CcSEcCtD
Decitabine—Epistaxis—Epirubicin—pancreatic cancer	2.09e-05	0.000474	CcSEcCtD
Decitabine—Pruritus—Gemcitabine—pancreatic cancer	2.09e-05	0.000474	CcSEcCtD
Decitabine—Infection—Docetaxel—pancreatic cancer	2.08e-05	0.000473	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—pancreatic cancer	2.08e-05	0.000472	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—pancreatic cancer	2.08e-05	0.000472	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	2.08e-05	0.000471	CcSEcCtD
Decitabine—Diarrhoea—Irinotecan—pancreatic cancer	2.08e-05	0.000471	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—pancreatic cancer	2.07e-05	0.000468	CcSEcCtD
Decitabine—Nervous system disorder—Docetaxel—pancreatic cancer	2.06e-05	0.000466	CcSEcCtD
Decitabine—Pruritus—Fluorouracil—pancreatic cancer	2.06e-05	0.000466	CcSEcCtD
Decitabine—Thrombocytopenia—Docetaxel—pancreatic cancer	2.05e-05	0.000466	CcSEcCtD
Decitabine—Infestation—Doxorubicin—pancreatic cancer	2.05e-05	0.000465	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—pancreatic cancer	2.05e-05	0.000465	CcSEcCtD
Decitabine—Tachycardia—Docetaxel—pancreatic cancer	2.05e-05	0.000464	CcSEcCtD
Decitabine—Skin disorder—Docetaxel—pancreatic cancer	2.04e-05	0.000462	CcSEcCtD
Decitabine—Diarrhoea—Gemcitabine—pancreatic cancer	2.02e-05	0.000459	CcSEcCtD
Decitabine—Renal failure—Doxorubicin—pancreatic cancer	2.02e-05	0.000457	CcSEcCtD
Decitabine—Dizziness—Irinotecan—pancreatic cancer	2.01e-05	0.000455	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—pancreatic cancer	2e-05	0.000454	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—pancreatic cancer	2e-05	0.000454	CcSEcCtD
Decitabine—Anorexia—Docetaxel—pancreatic cancer	2e-05	0.000453	CcSEcCtD
Decitabine—DCK—Metabolism—GLP1R—pancreatic cancer	2e-05	0.00176	CbGpPWpGaD
Decitabine—Urinary tract infection—Doxorubicin—pancreatic cancer	2e-05	0.000452	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—pancreatic cancer	1.99e-05	0.000452	CcSEcCtD
Decitabine—Diarrhoea—Fluorouracil—pancreatic cancer	1.99e-05	0.000451	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—pancreatic cancer	1.98e-05	0.000449	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—pancreatic cancer	1.98e-05	0.000448	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—pancreatic cancer	1.97e-05	0.000446	CcSEcCtD
Decitabine—DCK—Metabolism—DPYD—pancreatic cancer	1.97e-05	0.00173	CbGpPWpGaD
Decitabine—Oedema peripheral—Epirubicin—pancreatic cancer	1.96e-05	0.000445	CcSEcCtD
Decitabine—Hypotension—Docetaxel—pancreatic cancer	1.96e-05	0.000444	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—pancreatic cancer	1.96e-05	0.000444	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—pancreatic cancer	1.95e-05	0.000443	CcSEcCtD
Decitabine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	1.94e-05	0.00044	CcSEcCtD
Decitabine—Epistaxis—Doxorubicin—pancreatic cancer	1.94e-05	0.000439	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NOTCH1—pancreatic cancer	1.93e-05	0.0017	CbGpPWpGaD
Decitabine—Vomiting—Irinotecan—pancreatic cancer	1.93e-05	0.000437	CcSEcCtD
Decitabine—Sinusitis—Doxorubicin—pancreatic cancer	1.93e-05	0.000437	CcSEcCtD
Decitabine—Dizziness—Fluorouracil—pancreatic cancer	1.92e-05	0.000436	CcSEcCtD
Decitabine—Rash—Irinotecan—pancreatic cancer	1.91e-05	0.000434	CcSEcCtD
Decitabine—Dermatitis—Irinotecan—pancreatic cancer	1.91e-05	0.000433	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.91e-05	0.000433	CcSEcCtD
Decitabine—Headache—Irinotecan—pancreatic cancer	1.9e-05	0.000431	CcSEcCtD
Decitabine—Insomnia—Docetaxel—pancreatic cancer	1.9e-05	0.00043	CcSEcCtD
Decitabine—Vomiting—Gemcitabine—pancreatic cancer	1.88e-05	0.000426	CcSEcCtD
Decitabine—Dyspnoea—Docetaxel—pancreatic cancer	1.87e-05	0.000424	CcSEcCtD
Decitabine—DCK—Metabolism—SLC2A2—pancreatic cancer	1.87e-05	0.00164	CbGpPWpGaD
Decitabine—Rash—Gemcitabine—pancreatic cancer	1.86e-05	0.000423	CcSEcCtD
Decitabine—Dermatitis—Gemcitabine—pancreatic cancer	1.86e-05	0.000422	CcSEcCtD
Decitabine—Eye disorder—Epirubicin—pancreatic cancer	1.86e-05	0.000422	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—pancreatic cancer	1.85e-05	0.00042	CcSEcCtD
Decitabine—Headache—Gemcitabine—pancreatic cancer	1.85e-05	0.00042	CcSEcCtD
Decitabine—Cardiac disorder—Epirubicin—pancreatic cancer	1.85e-05	0.000419	CcSEcCtD
Decitabine—Vomiting—Fluorouracil—pancreatic cancer	1.85e-05	0.000419	CcSEcCtD
Decitabine—Dyspepsia—Docetaxel—pancreatic cancer	1.85e-05	0.000419	CcSEcCtD
Decitabine—Haemorrhage—Doxorubicin—pancreatic cancer	1.84e-05	0.000418	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—pancreatic cancer	1.83e-05	0.000416	CcSEcCtD
Decitabine—Rash—Fluorouracil—pancreatic cancer	1.83e-05	0.000415	CcSEcCtD
Decitabine—Dermatitis—Fluorouracil—pancreatic cancer	1.83e-05	0.000415	CcSEcCtD
Decitabine—Pharyngitis—Doxorubicin—pancreatic cancer	1.83e-05	0.000415	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—PPARG—pancreatic cancer	1.82e-05	0.00161	CbGpPWpGaD
Decitabine—Decreased appetite—Docetaxel—pancreatic cancer	1.82e-05	0.000413	CcSEcCtD
Decitabine—Headache—Fluorouracil—pancreatic cancer	1.82e-05	0.000413	CcSEcCtD
Decitabine—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.82e-05	0.000413	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—pancreatic cancer	1.82e-05	0.000412	CcSEcCtD
Decitabine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	1.81e-05	0.000411	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—pancreatic cancer	1.81e-05	0.000411	CcSEcCtD
Decitabine—Fatigue—Docetaxel—pancreatic cancer	1.81e-05	0.00041	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—pancreatic cancer	1.81e-05	0.00041	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—pancreatic cancer	1.81e-05	0.00041	CcSEcCtD
Decitabine—Nausea—Irinotecan—pancreatic cancer	1.8e-05	0.000409	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—pancreatic cancer	1.8e-05	0.000408	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—pancreatic cancer	1.8e-05	0.000407	CcSEcCtD
Decitabine—Constipation—Docetaxel—pancreatic cancer	1.79e-05	0.000407	CcSEcCtD
Decitabine—Pain—Docetaxel—pancreatic cancer	1.79e-05	0.000407	CcSEcCtD
Decitabine—Chills—Epirubicin—pancreatic cancer	1.79e-05	0.000405	CcSEcCtD
Decitabine—DNMT1—Gene Expression—SMAD4—pancreatic cancer	1.77e-05	0.00156	CbGpPWpGaD
Decitabine—Alopecia—Epirubicin—pancreatic cancer	1.76e-05	0.000399	CcSEcCtD
Decitabine—Nausea—Gemcitabine—pancreatic cancer	1.76e-05	0.000398	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—pancreatic cancer	1.75e-05	0.000396	CcSEcCtD
Decitabine—Erythema—Epirubicin—pancreatic cancer	1.73e-05	0.000393	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—pancreatic cancer	1.73e-05	0.000393	CcSEcCtD
Decitabine—Feeling abnormal—Docetaxel—pancreatic cancer	1.73e-05	0.000392	CcSEcCtD
Decitabine—Nausea—Fluorouracil—pancreatic cancer	1.73e-05	0.000391	CcSEcCtD
Decitabine—Eye disorder—Doxorubicin—pancreatic cancer	1.72e-05	0.00039	CcSEcCtD
Decitabine—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.72e-05	0.000389	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—pancreatic cancer	1.71e-05	0.000388	CcSEcCtD
Decitabine—Back pain—Epirubicin—pancreatic cancer	1.68e-05	0.00038	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—pancreatic cancer	1.67e-05	0.000379	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—pancreatic cancer	1.67e-05	0.000378	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—pancreatic cancer	1.66e-05	0.000377	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.66e-05	0.000377	CcSEcCtD
Decitabine—Abdominal pain—Docetaxel—pancreatic cancer	1.66e-05	0.000376	CcSEcCtD
Decitabine—Body temperature increased—Docetaxel—pancreatic cancer	1.66e-05	0.000376	CcSEcCtD
Decitabine—Chills—Doxorubicin—pancreatic cancer	1.65e-05	0.000375	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—pancreatic cancer	1.63e-05	0.00037	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—pancreatic cancer	1.63e-05	0.000369	CcSEcCtD
Decitabine—Mental disorder—Doxorubicin—pancreatic cancer	1.61e-05	0.000366	CcSEcCtD
Decitabine—Ill-defined disorder—Epirubicin—pancreatic cancer	1.61e-05	0.000365	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—pancreatic cancer	1.6e-05	0.000364	CcSEcCtD
Decitabine—Erythema—Doxorubicin—pancreatic cancer	1.6e-05	0.000364	CcSEcCtD
Decitabine—Anaemia—Epirubicin—pancreatic cancer	1.6e-05	0.000363	CcSEcCtD
Decitabine—Malaise—Epirubicin—pancreatic cancer	1.56e-05	0.000354	CcSEcCtD
Decitabine—Leukopenia—Epirubicin—pancreatic cancer	1.55e-05	0.000352	CcSEcCtD
Decitabine—Back pain—Doxorubicin—pancreatic cancer	1.55e-05	0.000352	CcSEcCtD
Decitabine—Hypersensitivity—Docetaxel—pancreatic cancer	1.55e-05	0.00035	CcSEcCtD
Decitabine—Muscle spasms—Doxorubicin—pancreatic cancer	1.54e-05	0.00035	CcSEcCtD
Decitabine—Cough—Epirubicin—pancreatic cancer	1.51e-05	0.000343	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—pancreatic cancer	1.51e-05	0.000343	CcSEcCtD
Decitabine—Asthenia—Docetaxel—pancreatic cancer	1.51e-05	0.000341	CcSEcCtD
Decitabine—Hypertension—Epirubicin—pancreatic cancer	1.5e-05	0.000339	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.49e-05	0.000337	CcSEcCtD
Decitabine—Pruritus—Docetaxel—pancreatic cancer	1.48e-05	0.000336	CcSEcCtD
Decitabine—Anaemia—Doxorubicin—pancreatic cancer	1.48e-05	0.000336	CcSEcCtD
Decitabine—Chest pain—Epirubicin—pancreatic cancer	1.48e-05	0.000335	CcSEcCtD
Decitabine—Myalgia—Epirubicin—pancreatic cancer	1.48e-05	0.000335	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—pancreatic cancer	1.48e-05	0.000335	CcSEcCtD
Decitabine—Anxiety—Epirubicin—pancreatic cancer	1.47e-05	0.000333	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.47e-05	0.000332	CcSEcCtD
Decitabine—Discomfort—Epirubicin—pancreatic cancer	1.46e-05	0.000331	CcSEcCtD
Decitabine—Malaise—Doxorubicin—pancreatic cancer	1.45e-05	0.000328	CcSEcCtD
Decitabine—DCK—Metabolism—CD44—pancreatic cancer	1.44e-05	0.00127	CbGpPWpGaD
Decitabine—Leukopenia—Doxorubicin—pancreatic cancer	1.44e-05	0.000326	CcSEcCtD
Decitabine—Diarrhoea—Docetaxel—pancreatic cancer	1.44e-05	0.000325	CcSEcCtD
Decitabine—Confusional state—Epirubicin—pancreatic cancer	1.43e-05	0.000323	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—pancreatic cancer	1.42e-05	0.000321	CcSEcCtD
Decitabine—Oedema—Epirubicin—pancreatic cancer	1.42e-05	0.000321	CcSEcCtD
Decitabine—Infection—Epirubicin—pancreatic cancer	1.41e-05	0.000319	CcSEcCtD
Decitabine—Cough—Doxorubicin—pancreatic cancer	1.4e-05	0.000317	CcSEcCtD
Decitabine—Nervous system disorder—Epirubicin—pancreatic cancer	1.39e-05	0.000315	CcSEcCtD
Decitabine—Dizziness—Docetaxel—pancreatic cancer	1.39e-05	0.000315	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—pancreatic cancer	1.39e-05	0.000314	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—pancreatic cancer	1.39e-05	0.000314	CcSEcCtD
Decitabine—DCK—Metabolism—GCG—pancreatic cancer	1.38e-05	0.00122	CbGpPWpGaD
Decitabine—Tachycardia—Epirubicin—pancreatic cancer	1.38e-05	0.000313	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—pancreatic cancer	1.37e-05	0.000312	CcSEcCtD
Decitabine—Arthralgia—Doxorubicin—pancreatic cancer	1.37e-05	0.00031	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—pancreatic cancer	1.37e-05	0.00031	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—pancreatic cancer	1.37e-05	0.00031	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—pancreatic cancer	1.36e-05	0.000309	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.36e-05	0.000308	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—pancreatic cancer	1.35e-05	0.000306	CcSEcCtD
Decitabine—Anorexia—Epirubicin—pancreatic cancer	1.35e-05	0.000306	CcSEcCtD
Decitabine—Vomiting—Docetaxel—pancreatic cancer	1.33e-05	0.000302	CcSEcCtD
Decitabine—Rash—Docetaxel—pancreatic cancer	1.32e-05	0.0003	CcSEcCtD
Decitabine—Hypotension—Epirubicin—pancreatic cancer	1.32e-05	0.0003	CcSEcCtD
Decitabine—Dermatitis—Docetaxel—pancreatic cancer	1.32e-05	0.0003	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—pancreatic cancer	1.32e-05	0.000299	CcSEcCtD
Decitabine—Headache—Docetaxel—pancreatic cancer	1.31e-05	0.000298	CcSEcCtD
Decitabine—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.31e-05	0.000297	CcSEcCtD
Decitabine—Oedema—Doxorubicin—pancreatic cancer	1.31e-05	0.000297	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NOTCH1—pancreatic cancer	1.31e-05	0.00115	CbGpPWpGaD
Decitabine—DCK—Metabolism—STK11—pancreatic cancer	1.3e-05	0.00115	CbGpPWpGaD
Decitabine—Infection—Doxorubicin—pancreatic cancer	1.3e-05	0.000295	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.29e-05	0.000292	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—pancreatic cancer	1.28e-05	0.000291	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.28e-05	0.000291	CcSEcCtD
Decitabine—Insomnia—Epirubicin—pancreatic cancer	1.28e-05	0.00029	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—pancreatic cancer	1.28e-05	0.00029	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—pancreatic cancer	1.27e-05	0.000288	CcSEcCtD
Decitabine—Dyspnoea—Epirubicin—pancreatic cancer	1.26e-05	0.000286	CcSEcCtD
Decitabine—Anorexia—Doxorubicin—pancreatic cancer	1.25e-05	0.000283	CcSEcCtD
Decitabine—Nausea—Docetaxel—pancreatic cancer	1.25e-05	0.000283	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—pancreatic cancer	1.25e-05	0.000282	CcSEcCtD
Decitabine—DNMT1—Gene Expression—PPARG—pancreatic cancer	1.23e-05	0.00108	CbGpPWpGaD
Decitabine—Decreased appetite—Epirubicin—pancreatic cancer	1.23e-05	0.000279	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—pancreatic cancer	1.22e-05	0.000277	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.22e-05	0.000277	CcSEcCtD
Decitabine—Fatigue—Epirubicin—pancreatic cancer	1.22e-05	0.000277	CcSEcCtD
Decitabine—Pain—Epirubicin—pancreatic cancer	1.21e-05	0.000274	CcSEcCtD
Decitabine—Constipation—Epirubicin—pancreatic cancer	1.21e-05	0.000274	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.19e-05	0.00027	CcSEcCtD
Decitabine—Insomnia—Doxorubicin—pancreatic cancer	1.18e-05	0.000268	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—pancreatic cancer	1.17e-05	0.000265	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—pancreatic cancer	1.17e-05	0.000264	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.16e-05	0.000262	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—pancreatic cancer	1.15e-05	0.000261	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—pancreatic cancer	1.14e-05	0.000258	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.13e-05	0.000256	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—pancreatic cancer	1.13e-05	0.000256	CcSEcCtD
Decitabine—Urticaria—Epirubicin—pancreatic cancer	1.12e-05	0.000255	CcSEcCtD
Decitabine—DCK—Metabolism—TYMS—pancreatic cancer	1.12e-05	0.000985	CbGpPWpGaD
Decitabine—Pain—Doxorubicin—pancreatic cancer	1.12e-05	0.000254	CcSEcCtD
Decitabine—Constipation—Doxorubicin—pancreatic cancer	1.12e-05	0.000254	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—pancreatic cancer	1.12e-05	0.000254	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—pancreatic cancer	1.12e-05	0.000254	CcSEcCtD
Decitabine—Feeling abnormal—Doxorubicin—pancreatic cancer	1.08e-05	0.000245	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.07e-05	0.000243	CcSEcCtD
Decitabine—Hypersensitivity—Epirubicin—pancreatic cancer	1.04e-05	0.000236	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—MYC—pancreatic cancer	1.04e-05	0.000915	CbGpPWpGaD
Decitabine—Urticaria—Doxorubicin—pancreatic cancer	1.04e-05	0.000236	CcSEcCtD
Decitabine—Body temperature increased—Doxorubicin—pancreatic cancer	1.04e-05	0.000235	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—pancreatic cancer	1.04e-05	0.000235	CcSEcCtD
Decitabine—Asthenia—Epirubicin—pancreatic cancer	1.02e-05	0.00023	CcSEcCtD
Decitabine—Pruritus—Epirubicin—pancreatic cancer	1e-05	0.000227	CcSEcCtD
Decitabine—Diarrhoea—Epirubicin—pancreatic cancer	9.68e-06	0.000219	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—pancreatic cancer	9.65e-06	0.000219	CcSEcCtD
Decitabine—Asthenia—Doxorubicin—pancreatic cancer	9.39e-06	0.000213	CcSEcCtD
Decitabine—Dizziness—Epirubicin—pancreatic cancer	9.36e-06	0.000212	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—pancreatic cancer	9.26e-06	0.00021	CcSEcCtD
Decitabine—DCK—Metabolism—APOE—pancreatic cancer	9.11e-06	0.000801	CbGpPWpGaD
Decitabine—Vomiting—Epirubicin—pancreatic cancer	9e-06	0.000204	CcSEcCtD
Decitabine—Diarrhoea—Doxorubicin—pancreatic cancer	8.96e-06	0.000203	CcSEcCtD
Decitabine—Rash—Epirubicin—pancreatic cancer	8.92e-06	0.000202	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—pancreatic cancer	8.91e-06	0.000202	CcSEcCtD
Decitabine—Headache—Epirubicin—pancreatic cancer	8.87e-06	0.000201	CcSEcCtD
Decitabine—Dizziness—Doxorubicin—pancreatic cancer	8.66e-06	0.000196	CcSEcCtD
Decitabine—Nausea—Epirubicin—pancreatic cancer	8.41e-06	0.000191	CcSEcCtD
Decitabine—Vomiting—Doxorubicin—pancreatic cancer	8.33e-06	0.000189	CcSEcCtD
Decitabine—Rash—Doxorubicin—pancreatic cancer	8.26e-06	0.000187	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—pancreatic cancer	8.25e-06	0.000187	CcSEcCtD
Decitabine—DCK—Metabolism—PIK3CG—pancreatic cancer	8.22e-06	0.000723	CbGpPWpGaD
Decitabine—Headache—Doxorubicin—pancreatic cancer	8.2e-06	0.000186	CcSEcCtD
Decitabine—DCK—Metabolism—PPARG—pancreatic cancer	7.93e-06	0.000698	CbGpPWpGaD
Decitabine—Nausea—Doxorubicin—pancreatic cancer	7.78e-06	0.000176	CcSEcCtD
Decitabine—DCK—Metabolism—PIK3CD—pancreatic cancer	7.23e-06	0.000636	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—AKT1—pancreatic cancer	7.21e-06	0.000635	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MYC—pancreatic cancer	7.03e-06	0.000618	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CB—pancreatic cancer	6.3e-06	0.000554	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTGS2—pancreatic cancer	6.24e-06	0.000549	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTEN—pancreatic cancer	5.44e-06	0.000479	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—AKT1—pancreatic cancer	4.87e-06	0.000429	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CA—pancreatic cancer	3.84e-06	0.000338	CbGpPWpGaD
Decitabine—DCK—Metabolism—AKT1—pancreatic cancer	3.14e-06	0.000276	CbGpPWpGaD
